MS
NTGN

Maven Securities’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Maven Securities’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-381,150
Closed -$1.01M – 597
2020
Q1 		$1.01M Buy
+381,150
New +$625K 0.12% 116

Maven Securities's NTGN Position: Q2 2020 in Review

Maven Securities sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 381,150 shares — an estimated $1.01M sold.

Maven Securities first reported a position in NTGN in Q1 2020 and held it in 1 quarter. The position peaked at $1.01M in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Maven Securities reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Maven Securities sold 381,150 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $1.01M.
  • Maven Securities first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Maven Securities's Neon Therapeutics, Inc. Common Stock position peaked at $1.01M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Maven Securities's 13F filing for Q2 2020, filed 14 Aug 2020.